Sam Altman-backed Retro Biosciences to raise $1bn for longevity mission
Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year ...
Raconteur16m
What do Trump’s $500bn Stargate initiative and regulatory cuts mean for AI safety?
The global regulatory outlook on AI is splintering between factions focused on investment and those more interested in safety ...
Times Republican7hOpinion
Corporations and billionaires flooded Trump’s inauguration with cash
President Trump sounded a lot of populist notes on the campaign trail. But as he took the oath of office for the second time, ...
'White House for sale?' Trump unveils multi-billion-dollar AI venture with OpenAI, SoftBank & Oracle
A closer look at OpenAI CEO Sam Altman after President Trump announces a multi-billion dollar joint venture between Altman's ...
Hosted on MSN26m
ChatGPT down as OpenAI tool refuses to work in mass outage with 'bad gateway' message
Visitors using the website were receiving a 'bad gateway' message. Netizens took to social media platforms like X to share ...
MIT Technology Review6d
OpenAI has created an AI model for longevity science
The company is making a foray into scientific discovery with an AI built to help manufacture stem cells. When you think of AI’s contributions to science, you probably think of AlphaFold, the ...
officechai.com1h
Microsoft CEO Satya Nadella Seemingly Throws Shade At Sam Altman’s Claims Of $500 Billion Investment
Sam Altman's announcement of having secured $500 billion in funding for building OpenAI's datacenters had been met with open ...